Zhejiang Huahai Pharmaceutical Co., Ltd.
SHH: 600521.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Bao Hua Chen
- Employees
- 8,221
- Headquarters
- Linhai, China
- IPO year
- 2003
- Market cap
- CN¥24.6B
- Website
- https://www.huahaipharm.com
Loading 600521…
Loading profile data…Frequently asked questions about 600521
What does Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) do?
Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also engages in packaging components business, such as high-density polyethylene bottles and polypropylene caps....
Where does 600521.SS trade?
Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) trades on the Shanghai Stock Exchange.
What sector is 600521.SS in?
Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Zhejiang Huahai Pharmaceutical Co., Ltd.?
Bao Hua Chen is the chief executive officer of Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS).
Where is Zhejiang Huahai Pharmaceutical Co., Ltd. headquartered?
Zhejiang Huahai Pharmaceutical Co., Ltd. is headquartered in China.
Does 600521.SS pay a dividend?
Yes — Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) paid a trailing twelve-month dividend of CNY 0.25 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600521.SS go public?
Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) completed its initial public offering in 2003.